Adaptive Biotechnologies ADPT Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's net income?
- Adaptive Biotechnologies (ADPT) reported net income of -$20.03M in Q1 2026.
- How has Adaptive Biotechnologies's net income changed year-over-year?
- Adaptive Biotechnologies's net income increased by 32.9% year-over-year, from -$29.85M to -$20.03M.
- What is the long-term trend for Adaptive Biotechnologies's net income?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's net income has grown at a -26.8% compound annual growth rate (CAGR), from -$207.28M to -$59.5M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.